NOVEL SULFATED POLYMERS AS HIGHLY POTENT AND SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION AND GIANT-CELL FORMATION

被引:117
作者
BABA, M
SCHOLS, D
DECLERCO, E
PAUWELS, R
NAGY, M
GYORGYIEDELENYI, J
LOW, M
GOROG, S
机构
[1] CATHOLIC UNIV LEUVEN, REGA INST MED RES, B-3000 LOUVAIN, BELGIUM
[2] EOTVOS LORAND UNIV, DEPT COLLOID SCI, H-1364 BUDAPEST 5, HUNGARY
[3] GEDEON RICHTER CHEM WORKS LTD, CHEM WORKS, H-1475 BUDAPEST, HUNGARY
关键词
D O I
10.1128/AAC.34.1.134
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Novel synthetic sulfated polymers, namely, sulfated polyvinyl alcohol (PVAS) and sulfated copolymers of acrylic acid with vinyl alcohol (PAVAS), proved to be potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in vitro. The compounds completely inhibited HIV-1-induced cytopathogenicity in MT-4 cells and HIV-1 antigen expression in CEM cells at a concentration of 0.8 μg/ml. They were equally effective against HIV-2 replication. In addition, and in contrast to azidothymidine, PAVAS and PVAS suppressed HIV-1-induced giant cell (syncytium) formation, a process that may account for the depletion of T4 lymphocytes in patients with acquired immunodeficiency syndrome. PAVAS and PVAS completely blocked giant cell formation at a concentration of 4 μg/ml, whereas for dextran sulfate a concentration of 100 μg/ml was required to achieve complete inhibition of giant cell formation. As has been demonstrated previously for the sulfated polysaccharides, the mechanism of action of PAVAS and PVAS resides in the inhibition of virus adsorption to the cells.
引用
收藏
页码:134 / 138
页数:5
相关论文
共 18 条
  • [1] PENTOSAN POLYSULFATE, A SULFATED OLIGOSACCHARIDE, IS A POTENT AND SELECTIVE ANTI-HIV AGENT INVITRO
    BABA, M
    NAKAJIMA, M
    SCHOLS, D
    PAUWELS, R
    BALZARINI, J
    DECLERCQ, E
    [J]. ANTIVIRAL RESEARCH, 1988, 9 (06) : 335 - 343
  • [2] MECHANISM OF INHIBITORY EFFECT OF DEXTRAN SULFATE AND HEPARIN ON REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS INVITRO
    BABA, M
    PAUWELS, R
    BALZARINI, J
    ARNOUT, J
    DESMYTER, J
    DECLERCQ, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) : 6132 - 6136
  • [3] De Clercq E, 1988, Verh K Acad Geneeskd Belg, V50, P166
  • [4] DECLERCQ E, 1987, TRENDS PHARMACOL SCI, V8, P339
  • [5] THE EFFICACY OF AZIDOTHYMIDINE (AZT) IN THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    FISCHL, MA
    RICHMAN, DD
    GRIECO, MH
    GOTTLIEB, MS
    VOLBERDING, PA
    LASKIN, OL
    LEEDOM, JM
    GROOPMAN, JE
    MILDVAN, D
    SCHOOLEY, RT
    JACKSON, GG
    DURACK, DT
    KING, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) : 185 - 191
  • [6] FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO
  • [7] 2-J
  • [8] HASELTINE WA, 1988, J ACQ IMMUN DEF SYND, V1, P217
  • [9] INHIBITORY EFFECT OF DEXTRAN SULFATE AND HEPARIN ON THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INVITRO
    ITO, M
    BABA, M
    SATO, A
    PAUWELS, R
    DECLERCQ, E
    SHIGETA, S
    [J]. ANTIVIRAL RESEARCH, 1987, 7 (06) : 361 - 367
  • [10] DIFFERENTIAL SUSCEPTIBILITY TO THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME RETROVIRUS IN CLONED CELLS OF HUMAN-LEUKEMIC T-CELL LINE MOLT-4
    KIKUKAWA, R
    KOYANAGI, Y
    HARADA, S
    KOBAYASHI, N
    HATANAKA, M
    YAMAMOTO, N
    [J]. JOURNAL OF VIROLOGY, 1986, 57 (03) : 1159 - 1162